Respiratory News and Research

RSS

3D-printed origami technology to aid in the fight against COVID-19

Researchers in Simon Fraser University’s Additive Manufacturing Lab are replicating a distinctive artform—the subtle folding of origami—to create 3D printable technologies to aid in the fight against COVID-19, and help doctors to identify and diagnose various health conditions.

9 Sep 2021

Duke surgeons perform first 'donation after circulatory death' pediatric heart transplant

Surgeons at Duke University Hospital successfully performed a "donation after circulatory death" (DCD) heart transplant in a pediatric patient, demonstrating the potential expansion of eligible donor hearts for children with heart failure.

9 Sep 2021

Report highlights the health effects of COVID-19 on Australians during 2020 and early 2021

A new report into the health effects of COVID-19 on Australians during 2020 and early 2021 includes analyses of the years of healthy life lost, international comparisons and impacts on population groups, mental health and the health system.

9 Sep 2021

Are bat retroviruses a threat to humans?

Zoonotic viruses that bats transmit are capable of infecting humans and have caused devastating infections throughout the world.

9 Sep 2021

Early impact of COVID-19 vaccines in Stockholm, Sweden

A study shows that the early programmatic effects of vaccinating high-risk individuals can reduce infection and mortality by SARS-CoV-2.

9 Sep 2021

Research probes interaction between SARS-CoV-2 and influenza

Researchers from Germany and France tried to determine if epidemiological studies based on co-detection prevalence data can offer a reliable estimation of interactions among respiratory viruses. They designed a simulation study by building on a general epidemiological model of co-circulation of 2 respiratory viruses that cause seasonal epidemics.

8 Sep 2021

Combating the fourth wave of COVID-19 in Ontario

Researchers from Canada recently attempted to project the number of COVID-19 cases and the demand for acute hospital resources for Fall 2021 in a mid-sized southwestern Ontario community. They sought to evaluate if current vaccine coverage and contact reduction levels are sufficient to mitigate a possible 4th wave driven by the Delta variant, or if stricter public health measures need to be reinstituted.

8 Sep 2021

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

Researchers in Japan have warned that the Mu (B.1.621) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – appears to be highly resistant to neutralization by sera from convalescent or vaccinated individuals.

8 Sep 2021

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.

8 Sep 2021

Breakthrough discovery could pave the way for new non-opioid painkillers to treat neuropathic pain

Monash University researchers have made a breakthrough discovery that could pave the way for the development of novel non-opioid painkillers to safely and effectively treat neuropathic pain.

8 Sep 2021

Neuropsychiatric symptoms in children and adolescents with long COVID

In a recent study, researchers determine the presence of any neuropsychological symptoms after recovering from COVID-19 in children and adolescents.

8 Sep 2021

The role of nanobodies in capturing and containing SARS-CoV-2

Scientists have repurposed the Nb Ty1 for the detection and neutralization of SARS-CoV-2.

8 Sep 2021

Infections during adolescence linked to increased risk of developing MS later in life

According to a new study, severe infections during adolescence may lead to an increased risk of contracting MS later in life. "We're talking mainly about brain and spinal cord infections, but also respiratory tract infections," says Scott Montgomery, professor at örebro University.

8 Sep 2021

Immunity induced by Pfizer/BioNTech COVID-19 vaccine declines with time, Mayo Clinic study finds

In a study conducted at the Mayo Clinic, USA, scientists have investigated the long-term efficacy of the mRNA-based coronavirus disease 2019 (COVID-19) vaccine BNT162b2 (Pfizer/BioNTech) against symptomatic disease.

8 Sep 2021

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus that causes coronavirus disease 2019 (COVID-19) – is not associated with neuroaxonal damage, according to a new study from researchers in Germany.

8 Sep 2021

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

A new study aimed to investigate the clinical, demographic, laboratory, neurophysiological, and imaging characteristics of children admitted to the ED with seizures and acute SARS-CoV-2 infection.

8 Sep 2021

AI can spot signs of lung cancer on CT scans a year earlier

An artificial intelligence (AI) program can spot signs of lung cancer on CT scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.

8 Sep 2021

Asthmatic children who are overweight or obese less likely to respond to inhaled steroids

Asthmatic children are less likely to respond to inhaled steroid medication if they are overweight or obese, and this leads to more frequent asthma attacks, according to research presented at the 'virtual' European Respiratory Society International Congress today (Wednesday).

8 Sep 2021

Researchers say modified COVID-19 vaccine boosters should control pandemic

Researchers in Texas have provided evidence for the need to modify the currently used coronavirus disease 2019 (COVID-19) vaccines to match circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Sep 2021

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

A new study successfully identifies a series of inhibitors that possesses pancoronavirus activity against SARS-CoV, SARS-CoV-2, and MERS-CoV.

7 Sep 2021

Respiratory News and Research

3D-printed origami technology to aid in the fight against COVID-19

Duke surgeons perform first 'donation after circulatory death' pediatric heart transplant

Report highlights the health effects of COVID-19 on Australians during 2020 and early 2021

Are bat retroviruses a threat to humans?

Early impact of COVID-19 vaccines in Stockholm, Sweden

Research probes interaction between SARS-CoV-2 and influenza

Combating the fourth wave of COVID-19 in Ontario

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Breakthrough discovery could pave the way for new non-opioid painkillers to treat neuropathic pain

Neuropsychiatric symptoms in children and adolescents with long COVID

The role of nanobodies in capturing and containing SARS-CoV-2

Infections during adolescence linked to increased risk of developing MS later in life

Immunity induced by Pfizer/BioNTech COVID-19 vaccine declines with time, Mayo Clinic study finds

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

AI can spot signs of lung cancer on CT scans a year earlier

Asthmatic children who are overweight or obese less likely to respond to inhaled steroids

Researchers say modified COVID-19 vaccine boosters should control pandemic

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News